C4 Therapeutics logo
C4 Therapeutics CCCC
$ 6.14 -4.8%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

C4 Therapeutics ROCE Ratio 2011-2024 | CCCC

Annual ROCE Ratio C4 Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-56.49 -44.79 -21.08 -16.97 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-16.97 -56.49 -34.83

Quarterly ROCE Ratio C4 Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-45.67 -46.9 -54.29 -42.75 -52.96 -50.3 -42.17 -26.76 -32.84 -28.72 -26.08 -19.17 -25.7 -26.16 -24.71 -14.8 -5.86 9.6 13.47 8.93 8.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
13.47 -54.29 -25.0